Murdoch Childrens Research Institute
Clinical trials sponsored by Murdoch Childrens Research Institute, explained in plain language.
-
Booster battle: moderna vs novavax for fourth COVID shot
⭐️ VACCINE ⭐️ OngoingThis study tests two different COVID-19 booster vaccines—Moderna's bivalent mRNA and Novavax's protein-based—in 496 healthy adults who have already had three doses. The goal is to see which booster produces a stronger immune response and causes fewer side effects. Participants wi…
Phase: PHASE3 • Sponsor: Murdoch Childrens Research Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:53 UTC
-
New study aims to save tiny lungs: which PEEP level works best?
Disease control OngoingThis study compares two methods of giving breathing support (PEEP) to very premature babies right after birth. About 900 babies born between 23 and 28 weeks will be randomly assigned to receive either a steady PEEP level or a high-then-low approach. The goal is to see which metho…
Phase: NA • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Vitamin d trial aims to stop food allergies in infants
Prevention OngoingThis study tests whether giving vitamin D supplements to healthy, breastfed babies during their first year can prevent food allergies. Over 2,700 infants in Australia are participating. Researchers will check for food allergies at 12 months and again at 6 years old.
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Prevention
Last updated May 17, 2026 03:31 UTC
-
Dads unite: new study tests peer support to beat baby blues
Symptom relief OngoingThis study tests a 6-week group program called Working Out Dads (WOD) to see if it helps reduce mental health struggles in fathers of children aged 0-4. About 293 dads with mild to moderate distress will either join the WOD peer-support group or receive usual care. The goal is to…
Phase: NA • Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated May 17, 2026 03:25 UTC
-
New study aims to find safe scabies treatment for toddlers
Knowledge-focused OngoingThis study looks at how well a single dose of ivermectin works in young children (3 months to under 5 years) with scabies. Researchers want to find the right dose that is both safe and effective for this age group. The study involves 120 children in Laos and is part of a larger n…
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
New infant ivermectin formula put to the test in healthy adults
Knowledge-focused TerminatedThis study tests a new liquid version of the drug ivermectin, designed for infants, against the standard tablet. 52 healthy adults will try both forms to see if they work the same, taste okay, and are safe. The goal is to make treating scabies easier for babies.
Phase: PHASE1 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC